Articles by Suma Ray, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Suma Ray, PhD

Key Considerations for Development and Production of Vaccine Products

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
Mar 2, 2012

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.

Challenges and Trends in Vaccine Manufacturing

An evaluation of the technologies and process parameters needed to develop a safe, effective, and economically efficient vaccine. This article is part of a special section on vaccines.
Oct 2, 2011

An evaluation of the technologies needed to develop a safe, effective, and economically efficient vaccine. This article is part of a special section on vaccines.

Virus Clearance Strategy Using a Three-Tier Orthogonal Technology Platform

How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
Oct 2, 2009

How to implement a risk-based approach to eliminate viruses using orthogonal technologies.

Viral Clearance Strategy Using a Three-Tier Orthogonal Technology Platform

How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
Sep 1, 2008

How to implement a risk-based approach to eliminating viruses.

ADVERTISEMENT

ADVERTISEMENT

Click here